Jinling Zhang

Harbin Medical University

Papers

1

Total Citations

10

H-Index

1

About

Dr. Jinling Zhang is a biomedical researcher whose work centers on diabetic complications, particularly diabetic nephropathy (DN), a leading cause of renal failure worldwide. Her most cited study, "Protective Effects of Xanthohumol against Diabetic Nephropathy in a Mouse Model" (2023), has garnered 10 citations and addresses the urgent need for novel therapies. This work investigates the natural compound xanthohumol, demonstrating its potential to mitigate kidney damage in diabetic models, offering a promising avenue for treatment beyond current, often inadequate, options. By targeting the underlying mechanisms of DN—a condition contributing to millions of deaths annually—Dr. Zhang’s research highlights the therapeutic value of bioactive compounds in managing chronic disease. Her contributions are particularly significant given the rising global diabetes epidemic, where effective interventions remain scarce. Through rigorous preclinical studies, she provides foundational evidence that could translate into clinical strategies, improving outcomes for patients facing progressive renal decline. Dr. Zhang’s work exemplifies a commitment to addressing critical gaps in diabetic care, positioning her as a key voice in nephropathy research.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Protective Effects of Xanthohumol against Diabetic Nephropathy in a Mouse Model
10 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Harbin Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago